Researchers have successfully edited the genome of human- induced pluripotent stem cells, making possible the future development of patient-specific stem cell therapies. They altered a gene responsible for causing the rare blood disease paroxysmal nocturnal hemoglobinuria, or PNH, establishing for the first time a useful system to learn more about the disease.